Skylight Health Announces Re-Appointment of Co-Founder Kash Qureshi as President
2022年7月14日 - 9:30PM
Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight
Health” or the “Company”), a multi-state primary care management
group in the United States, today announced the re-appointment of
Co-Founder and current Director and Chief Corporate Officer Kash
Qureshi as President.
Prad Sekar, CEO and Co-Founder of Skylight Health said, “What
has made us resilient in any environment is having both co-founders
working side by side for over 12 years. Kash and I will continue to
execute our plan to bring Skylight into profitability in 2022. We
are fortunate to have an experienced and highly capable senior
management team who will continue to lead our company and focus on
returning shareholder value. The Company thanks Mohammad Bataineh
for his contributions and wishes him the best in the future.”
Kash Qureshi, Co-Founder of Skylight Health, will replace
Mohammad Bataineh as President, and will remain an Executive Member
of the Board of Directors.
About Skylight Health
Group
Skylight Health Group (NASDAQ:SLHG;TSXV:SLHG) is
a healthcare services and technology company, working to positively
impact patient health outcomes. The Company operates a US
multi-state primary care health network comprised of physical
practices providing a range of services from primary care,
sub-specialty, allied health, and laboratory/diagnostic testing.
The Company is focused on helping small and independent practices
shift from a traditional fee-for-service (FFS) model to value-based
care (VBC) through tools including proprietary technology, data
analytics, and infrastructure. In an FFS model, payors (commercial
and government insurers) reimburse on an encounter-based approach.
This puts a focus on the volume of patients per day. In a VBC
model, the providers offer care that is aimed at keeping patients
healthy and minimizing unnecessary health expenditures that are not
proven to maintain the patient’s well-being. This places an
emphasis on quality over volume. VBC will lead to improved patient
outcomes, reduced cost of delivery and drive stronger financial
performance from existing practices.
Forward Looking Statements
This press release may include predictions,
estimates or other information that might be considered
forward-looking within the meaning of applicable securities laws.
While these forward-looking statements represent our current
judgments, they are subject to risks and uncertainties that could
cause actual results to differ materially. You are cautioned not to
place undue reliance on these forward-looking statements, which
reflect our opinions only as of the date of this release. Please
keep in mind that we are not obligating ourselves to revise or
publicly release the results of any revision to these
forward-looking statements in light of new information or future
events. When used herein, words such as "look forward," "believe,"
"continue," "building," or variations of such words and similar
expressions are intended to identify forward-looking statements.
Factors that could cause actual results to differ materially from
those contemplated in any forward-looking statements made by us
herein are often discussed in filings we make with the Canadian and
United States securities regulators, including the Securities and
Exchange Commission, available at: www.sec.gov, and Canadian
Securities Administrators, available at www.sedar.com, and on
our website, at skylighthealthgroup.com.
For more information, please visit our website or contact:
Investor Relations:Jackie
Kellyinvestors@skylighthealthgroup.com416-301-2949
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Skylight Health (NASDAQ:SLHG)
過去 株価チャート
から 5 2024 まで 6 2024
Skylight Health (NASDAQ:SLHG)
過去 株価チャート
から 6 2023 まで 6 2024